Abstract: An impeller (230) for a planet carrier of a planetary gear speed reducer of a turbomachine, is configured intended to be rotatably secured to the planet carrier and to be rotated about an axis A of the speed reducer. The impeller has an annular shape about the axis and includes lubrication means (43, 45, 238), in particular for lubricating bearings of planet gears of the speed reducer. The lubrication means include an annular cavity (238) situated at the inner periphery of the impeller. The impeller includes an inner peripheral wall (246) closing the cavity (238) in the radial direction, and the impeller includes an annular port (248) that extends around the axis and that opens in the axial direction into the cavity in order to supply it with lubricating oil.

Abstract: A turbofan engine has a primary duct, in which there flows a primary flow at a primary pressure and a secondary duct, which radially surrounds the primary duct and in which there flows a secondary flow at a secondary pressure. The primary duct includes at least one compressor configured to compress the primary flow, a turbine driving the compressor in rotation and a combustion chamber designed to receive, at an inlet, the primary air flow compressed by the compressor. The turbomachine further includes a cooling circuit extending between the compressor and the turbine. The cooling circuit has an air flow rate regulating device arranged upstream of the turbine and having at least one valve that is configured to move between an open position and a closed position, located between the compressor and the combustion chamber in the primary duct and the pressure (PS) in the secondary duct.

Abstract: A turbofan engine has a primary duct , in which there flows a primary flow at a primary pressure and a secondary duct, which radially surrounds the primary duct and in which there flows a secondary flow at a secondary pressure. The primary duct includes at least one compressor configured to compress the primary flow , a turbine driving the compressor in rotation and a combustion chamber designed to receive, at an inlet, the primary air flow compressed by the compressor The turbomachine further includes a cooling circuit extending between the compressor and the turbine.The cooling circuit has an air flow rate regulating device arranged upstream of the turbine and having at least one valve that is configured to move between an open position and a closed position, located between the compressor and the combustion chamber in the primary duct and the pressure (PS) in the secondary duct.

Abstract: An impeller (230) for a planet carrier of a planetary gear speed reducer of a turbomachine, is configured intended to be rotatably secured to the planet carrier and to be rotated about an axis A of the speed reducer. The impeller has an annular shape about the axis and includes lubrication means (43, 45, 238), in particular for lubricating bearings of planet gears of the speed reducer. The lubrication means include an annular cavity (238) situated at the inner periphery of the impeller. The impeller includes an inner peripheral wall (246) closing the cavity (238) in the radial direction, and the impeller includes an annular port (248) that extends around the axis and that opens in the axial direction into the cavity in order to supply it with lubricating oil.

Abstract: Disclosed are compounds, compositions and methods for treating of diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT1. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, R4, R5, R6, R5, G1, and G2 are defined herein.

Abstract: A turbine engine including a fan shaft driven by a turbine shaft with a rotational speed reduction device. A decoupling element is interposed between the reduction device and the fan shaft which operates to decouple the reduction device and the fan shaft. The reduction device is coupled to the fan shaft by a coupling having trapezoidal teeth of the curvic type which are used during the said decoupling operation. The decoupling element is configured to decouple the reduction device and the fan shaft in response to a predetermined resistive torque, referred to as the decoupling torque, which acts between the fan shaft and the reduction device.

Abstract: Disclosed are compounds, compositions and methods for treating of diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT1. Such compounds are represented by Formula (I) as follows: wherein the variables are defined herein.

Abstract: A turbomachine having a fan shaft supported by a first bearing positioned downstream of the fan, the first bearing including an outer ring attached to an annular support secured to the stator. The turbomachine includes at least one gas feed duct leading into an enclosure positioned against the disc, the gas feed duct being adapted to be fed at a second end with pressurized gas taken from an airstream of a high-pressure compressor of the turbomachine, so that the gas applies an axial force towards upstream on the disc during some operating phases of the turbomachine. The turbomachine further includes a ferrule imperviously sealing the enclosure.

Abstract: The present invention relates to substituted quinoxaline and pyridopyrazine derivatives of Formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as pI3K? inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

Abstract: An aircraft propulsion assembly, including a turbine engine comprising at least one gas generator configured to generate a main flow, which is supplied by a central jet to at least one power turbine, the central jet being surrounded by an outer fairing, and the power turbine driving, on the periphery thereof, at least one fan rotor. The aircraft propulsion assembly comprises first movable means which are arranged so as to divert at least some of the main flow from the central jet to the outside of the outer fairing and preferably upstream of the turbine engine so as to generate thrust reversal. An aircraft which uses the propulsion assembly, particularly on the rear tip of the fuselage of the aircraft.

Abstract: The present invention relates to substituted quinoxaline and pyridopyrazine derivatives of Formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as pI3K? inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

Abstract: A turbojet of the unducted rotor type and an aircraft including such a turbojet, the turbojet including a gas generator, a first unducted propeller connected to a shaft of the gas generator via first reduction gearing, and a second unducted propeller connected to a shaft of the gas generator via second reduction gearing, wherein the first propeller and the first reduction gearing are mounted at the front of the gas generator, and wherein the second propeller and the second reduction gearing are mounted at the rear of the gas generator.

Abstract: A system for controlling the pitch of fan blades of a turbine engine propeller, the system including an actuator secured to a casing of the turbine engine, having a movable portion that is movable in translation relative to the casing, the movable portion being mechanically coupled to a load transfer bearing having an outer ring that is coupled to fan blade pivots so that a movement in translation of the movable portion of the actuator leads to a change in the pitch angle of the fan blades, and at least one locking peg secured to the casing of the turbine engine and suitable, in the event of the actuator malfunctioning, for mechanically locking the load transfer bearing in a position wherein the fan blades are feathered.

Abstract: Disclosed are compounds, compositions and methods for treating of diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT1. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, R4, R5, R6, R5, G1, and G2 are defined herein.

Abstract: The present invention relates novel substituted nucleoside analogues of Formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as PRMT5 inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

Abstract: The present invention relates to bicyclic pyridine, pyrazine, and pyrimidine derivatives of Formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as pI3K? inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

Abstract: Disclosed are compounds, compositions and methods for treating of diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT1. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, R4, R5, R6, R7, G1 and G2, are defined herein.

Abstract: The present invention relates novel substituted nucleoside analogues of Formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as PRMT5 inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

Abstract: The present invention relates to substituted quinoxaline and pyridopyrazine derivatives of Formula I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as pI3K? inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

Abstract: The present invention relates to substituted quinoxaline and pyridopyrazine derivatives of Formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as pI3K? inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.